Cancer Research
- Altogen Biosystems Launches Custom Biotechnology Research Services: Generation Of Stable Cell Lines And RNAi Cell Transfection S
-
LAS VEGAS, March 11 /PRNewswire/-- Altogen Biosystems (http://www.altogen.com) announced launch of new contract research services. Located in Las Vegas, NV, Altogen Custom Services focus on providing specialized biotechnology and pharmaceutical services, ...
Article - Anna Ohlden - Mar 11 2008 - 7:32am
- Macrophages, Over-Expression And The Kind Of ID That Doesn't Make Biologists Cringe
-
Macrophages, derived from Greek and meaning “eating cells”, are biological cells that spring from white blood cells to destroy foreign or dying cells. They are basically cellular “policemen” that can differentiate between good and bad cells. But some cance ...
Article - News Staff - Mar 11 2008 - 2:26pm
- Yeast, Sex, And You
-
Wild sex is a staple of nature films, but there is one sex scene David Attenborough has never narrated: the mating ritual of yeast. That's right: yeast. Sex isn't just limited to lions, birds of paradise, and aphids; single-celled fungi do it too ...
Article - Michael White - May 26 2009 - 10:45pm
- Thomson Scientific Names 'Hottest' Researchers And Papers Of 2006-2007
-
PHILADELPHIA and LONDON, March 12 /PRNewswire/--- Osaka's Shizuo Akira Ranks Among The Hottest for Fourth Year; Once Again, United States Accounts for More Than Half of the Top Researchers Thomson Scientific today announced the results of its annual ...
Article - Anna Ohlden - Mar 12 2008 - 12:42pm
- Identified: 25 Genes That Regulate Lifespan
-
Researchers have identified 25 genes regulating lifespan in two organisms separated by about 1.5 billion years in evolutionary change. At least 15 of those genes have very similar versions in humans, suggesting that scientists may be able to target those g ...
Article - News Staff - Mar 12 2008 - 6:46pm
- Abbott's HUMIRA(R) (adalimumab) Shows Long-Term Improvement In Fistula Response And Healing Rates In Difficult-to-Treat Patients
-
ABBOTT PARK, Illinois, March 13 /PRNewswire/--- Two Sub Analyses from the CHARM Trial Evaluated Fistula Closure and Quality Of Life in Patients with Fistulas from Crohn's Disease Abbott announced today the first two-year data for Crohn's disease ...
Article - Anna Ohlden - Mar 13 2008 - 4:30am
- Stonegate Report About Unigene Laboratories Inc.
-
ZURICH, Switzerland and FAIRFIELD, New Jersey, March 13 /PRNewswire/-- "The new Stonegate Report about Unigene confirms that we are uniquely positioned as the only biopharma company that manufactures peptides by recombinant techniques, while also hav ...
Article - Anna Ohlden - Mar 13 2008 - 7:33am
- Silence Therapeutics And AstraZeneca Announce Collaboration To Develop Novel Approaches For SiRNA Drug Delivery
-
LONDON, March 13 /PRNewswire/-- Silence Therapeutics plc (AIM: SLN) today announces a collaboration with AstraZeneca (LSE: AZN), focused on the development of a range of novel approaches for the delivery of siRNA molecules. The deal builds on Silence Ther ...
Article - Anna Ohlden - Mar 13 2008 - 11:35am
- Cellectis Sues Precision BioSciences For Infringement Of Its Patents Concerning Meganuclease Technology
-
...
Article - Anna Ohlden - Mar 13 2008 - 4:30pm
- BMJ Article- Avoid Genetic Scams By Regulating Tests
-
Better regulation is urgently needed for genetic tests, particularly those marketed directly to the public, argue researchers in this week’s BMJ. In the past 18 months, studies have identified dozens of inherited DNA variations associated with common condi ...
Article - News Staff - Mar 13 2008 - 11:56pm